Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Anticancer Research|August 5, 2003
Enhancement of Fas-ligand-mediated programmed cell death by taurolidineRuediger Stendel, Louis Scheurer, Gisela Stoltenburg-Didinger, et al.
Neurobiology of Learning and Memory|May 21, 2011
Examining the sex- and circadian dependency of a learning phenotype in mice with glycine transporter 1 deletion in two Pavlovian conditioning paradigmsSylvain Dubroqua, Detlev Boison, Joram Feldon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 22, 2010
Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in micePhilipp Singer, Detlev Boison, Hanns Möhler, et al.
Behavioral Neuroscience|October 15, 2009
Deletion of glycine transporter 1 (GlyT1) in forebrain neurons facilitates reversal learning: enhanced cognitive adaptability?Philipp Singer, Detlev Boison, Hanns Möhler, et al.
Behavioral Neuroscience|October 3, 2007
Enhanced recognition memory following glycine transporter 1 deletion in forebrain neuronsPhilipp Singer, Detlev Boison, Hanns Möhler, et al.
Epilepsia|August 16, 2002
Seizure suppression by adenosine-releasing cells is independent of seizure frequencyDetlev Boison, Alexander Huber, Vivianne Padrun, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 31, 2009
Research in anxiety disorders: from the bench to the bedsideMatthew Garner, Hanns Möhler, Dan J Stein, et al.
Behavioral Neuroscience|November 3, 2010
Impacts of forebrain neuronal glycine transporter 1 disruption in the senescent brain: evidence for age-dependent phenotypes in Pavlovian learningSylvain Dubroqua, Philipp Singer, Detlev Boison, et al.
Pharmacology, Biochemistry, and Behavior|May 6, 2008
Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1Hanns Möhler, Uwe Rudolph, Detlev Boison, et al.
Biochemical Pharmacology|February 22, 2011
Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibitionHanns Möhler, Detlev Boison, Philipp Singer, et al.
Pageof 4